<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="0" ids="30621">Arsenic trioxide</z:chebi> has become the treatment of choice for patients with <z:hpo ids='HP_0011009'>acute</z:hpo> promyelocytic <z:mpath ids='MPATH_336'>leukaemia</z:mpath> </plain></SENT>
<SENT sid="1" pm="."><plain>Cardiovascular toxicity is known to occur with this therapy, in particular <z:hpo ids='HP_0011675'>heart rhythm disorders</z:hpo> due to QT interval prolongation </plain></SENT>
<SENT sid="2" pm="."><plain>We present a case of <z:hpo ids='HP_0004308'>ventricular arrhythmia</z:hpo> with no QT prolongation in a patient receiving <z:chebi fb="0" ids="30621">arsenic trioxide</z:chebi> therapy </plain></SENT>
</text></document>